UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000043994 |
|---|---|
| Receipt number | R000050243 |
| Scientific Title | Comparative efficacy and safety of lorlatinib and alectinib for ALK rearrangement positive advanced non-small cell lung cancer in Asian and non-Asian patients: systematic review and network meta-analysis. |
| Date of disclosure of the study information | 2021/04/22 |
| Last modified on | 2021/06/26 10:43:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/04/21 10:25:56 | ||
| 2 | Update | 2021/06/02 10:06:57 | Public title Public title Scientific Title Scientific Title |
|
| 3 | Update | 2021/06/02 10:19:57 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2021/06/02 10:23:51 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2021/06/26 10:29:50 | Recruitment status Date of IRB |
|
| 6 | Update | 2021/06/26 10:40:23 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2021/06/26 10:43:28 | Last follow-up date |
